|
|||||
|
|
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): results in the pre‐specified subgroup with heart failure |
|
| Authors: | Patrick Rossignol Bryan Williams Martha R. Mayo Suzette Warren Susan Arthur Gail Ackourey William B. White Rajiv Agarwal |
| Abstract: | |
| Keywords: | Heart failure Chronic kidney disease Hyperkalaemia Patiromer Resistant hypertension Spironolactone |